Cortisone Injection vs PRP Injection

Cortisone targets inflammation for symptom control, while PRP uses concentrated blood components; neither injection suits every diagnosis.

Cortisone is a medicine intended to settle inflammation in a joint or surrounding tissue. PRP is prepared from a blood sample and injected into a selected area; it is used with the aim of supporting a healing response. The choice is not simply about which injection is stronger. It depends on whether inflammation, tendon or ligament tissue, joint wear, or another source is driving the symptoms.

Cortisone may fit when inflammation is a prominent part of the diagnosis and relatively prompt symptom control is the goal. It can be discussed for selected joint, bursa, or tendon-sheath problems after assessment. People with diabetes should ask about temporary glucose changes; anyone with an infection near the planned site should report it before treatment.

PRP may be discussed when the clinician is targeting a tendon or other soft-tissue problem and wants a treatment based on the patient’s own blood components. It requires a blood draw and a tailored recovery period. Ask how the preparation is made, whether activity must be reduced, and how progress will be judged over follow-up visits.

Both injections can cause soreness, bruising, bleeding, or infection. PRP commonly involves temporary local irritation as the tissue responds, while cortisone may briefly raise blood glucose and is not appropriate for every tissue or diagnosis. A clinician should review blood disorders, blood-thinning medicines, infection, allergies, and the exact injection site. Increasing redness, fever, severe pain, or new weakness needs medical review.

An injection may be the wrong first step if symptoms suggest a fracture, major tear, nerve compression, infection, or a problem requiring surgery. Exercise-based rehabilitation, load modification, imaging, medicines, or another specialist treatment may address the cause more directly. Persistent pain despite an injection should trigger reassessment rather than automatic repetition.

The clinician weighs the confirmed diagnosis, tissue involved, symptom duration, examination, previous care, medical history, medicines, and the practical recovery plan. They should explain what the injection is intended to change and when review is needed. A useful appointment question is whether the proposed injection treats the source of pain or mainly provides a window for rehabilitation.